Targeted Inhibition of FTO Demethylase Protects Mice Against LPS-Induced Septic Shock by Suppressing NLRP3 Inflammasome

Jia‐Hui Luo(Tongji Hospital), Faxi Wang(Tongji Hospital), Fei Sun(Tongji Hospital), Tiantian Yue(Tongji Hospital), Qing Zhou(Tongji Hospital), Chunliang Yang(Tongji Hospital), Shan-Jie Rong(Tongji Hospital), Ping Yang(Tongji Hospital), Fei Xiong(Tongji Hospital), Qilin Yu(Tongji Hospital), Shu Zhang(Tongji Hospital), Cong‐Yi Wang(Tongji Hospital), Jinxiu Li(Central South University)
Frontiers in Immunology
May 4, 2021
Cited by 73Open Access
Full Text

Abstract

Sepsis refers to the systemic inflammatory response syndrome caused by infection. It is a major clinical problem and cause of death for patients in intensive care units worldwide. The Fat mass and obesity-related protein (FTO) is the primary N 6 -methyladenosine demethylase. However, the role of FTO in the pathogenesis of inflammatory diseases remains unclear. We herein show that nanoparticle-mediated Fto -siRNA delivery or FTO inhibitor entacapone administration dramatically inhibited macrophage activation, reduced the tissue damage and improved survival in a mouse model of LPS-induced endotoxic shock. Importantly, ablation of FTO could inhibit NLRP3 inflammasome through FoxO1/NF-κB signaling in macrophages. In conclusion, FTO is involved in inflammatory response of LPS-induced septic shock and inhibition of FTO is promising for the treatment of septic shock.


Related Papers

No related papers found

Powered by citation graph analysis